Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among HIV-positive people, mortality related to hepatitis B and C is falling but deaths due to NAFLD are rising.
Patient advocacy groups get together, providing education about this little-known disease.
Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.
Nearly a quarter of those taking a higher dose of Ocaliva saw an improvement in liver scarring.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
Although it seems like common sense, one of the first rigorous studies on the subject shows a clear association.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.